Belibakt has pronounced bactericidal activity against a wide range of clinically significant strains of gram-positive and gram-negative aerobes, incl. nosocomial, resistant to other antibiotics.
each bottle contains:
Bacterial infections caused by pathogens sensitive to the drug:
The drug is also used to prevent infectious complications in the preoperative and postoperative periods.
Intravenously and intramuscularly.
Adults and children over 12 years old – 1-2 g (calculated as ceftriaxone) 1 time per day or 0.5-1 g every 12 hours, the daily dose should not exceed 4 g.
For newborns (up to 2 weeks) – 20-50 mg/kg per day.
For infants and children under 12 years of age, the daily dose is 20-80 mg/kg. In children weighing 50 kg and above, adult doses are used.
A dose of more than 50 mg/kg body weight should be administered as an intravenous infusion over 30 minutes. The duration of the course depends on the nature and severity of the disease.
For gonorrhea – intramuscularly, once, 250 mg.
To prevent postoperative complications – once, 1-2 g (depending on the degree of danger of infection) 30-90 minutes before the start of surgery.
During operations on the colon and rectum, additional administration of a drug from the group of 5-nitroimidazoles is recommended.
For bacterial meningitis in infants and young children – 100 mg/kg (but not more than 4 g) 1 time per day. The duration of treatment depends on the pathogen and can range from 4 days for Neisseria meningitidis to 10-14 days for sensitive strains of Enterobacteriaceae.
Children with skin and soft tissue infections – a daily dose of 50-75 mg/kg once a day or 25-37.5 mg/kg every 12 hours, not more than 2 g per day.
For severe infections of other localization – 25-37.5 mg/kg every 12 hours, no more than 2 g per day. For otitis media – intramuscularly, once, 50 mg/kg, not more than 1 g.